Chargement en cours...

Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function

Nasolacrimal duct obstruction (NLDO) is thought to be due to inflammation and fibrosis of lacrimal duct epithelial cells (LDECs). Here we investigated the effect of rebamipide, a drug that is used for the protection of the mucosa and the treatment of gastritis and gastroduodenal ulcers, on LDECs, bo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Tanaka, Hiroshi, Nakayama, Tomomichi, Tsukamoto, Michiko, Watanabe, Akihide, Nakamura, Takahiro, Yokoi, Norihiko, Sotozono, Chie, Kinoshita, Shigeru
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6997454/
https://ncbi.nlm.nih.gov/pubmed/32015381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-58314-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!